一名类风湿关节炎患者在接受肿瘤坏死因子-α拮抗剂治疗期间发生坏疽性脓皮病。 - Suppr

Suppr

超能文献

Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritis.

作者信息

Vandevyvere K, Luyten F P, Verschueren P, Lories R, Segaert S, Westhovens R

机构信息

Division of Rheumatology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium.

Division of Dermatology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium.

出版信息

Clin Rheumatol. 2007 Dec;26(12):2205-2206. doi: 10.1007/s10067-007-0733-8. Epub 2007 Sep 18.

DOI:10.1007/s10067-007-0733-8

PMID:17876646

Abstract

摘要

相似文献

Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritis.一名类风湿关节炎患者在接受肿瘤坏死因子-α拮抗剂治疗期间发生坏疽性脓皮病。

Clin Rheumatol. 2007 Dec;26(12):2205-2206. doi: 10.1007/s10067-007-0733-8. Epub 2007 Sep 18.

Pyoderma gangrenosum in a patient with seronegative rheumatoid arthritis during therapy with adalimumab: toxic effects of adalimumab or failure of adalimumab to prevent the onset of this phenomenon?一名血清阴性类风湿关节炎患者在使用阿达木单抗治疗期间发生坏疽性脓皮病：是阿达木单抗的毒性作用还是阿达木单抗未能预防该现象的发生？

Arch Dermatol. 2008 Jun;144(6):817-8. doi: 10.1001/archderm.144.6.817.

Use of infliximab in a patient with pyoderma gangrenosum and rheumatoid arthritis.应用英夫利昔单抗治疗坏疽性脓皮病合并类风湿关节炎 1 例

Mod Rheumatol. 2010 Dec;20(6):598-601. doi: 10.1007/s10165-010-0336-0. Epub 2010 Aug 4.

Paradoxical reactions to targeted biological treatments: A way to treat and trigger?靶向生物治疗的矛盾反应：一种治疗和触发的方式？

Acta Derm Venereol. 2010 Mar;90(2):183-5. doi: 10.2340/00015555-0777.

Serious infections under treatment with TNF-alpha antagonists compared to traditional DMARDs in patients with rheumatoid arthritis.类风湿关节炎患者中，与传统改善病情抗风湿药相比，接受肿瘤坏死因子-α拮抗剂治疗时的严重感染情况。

Rheumatol Int. 2006 Nov;27(1):67-71. doi: 10.1007/s00296-006-0165-9. Epub 2006 Aug 2.

Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.接受抗TNF-α药物治疗的类风湿关节炎患者发生带状疱疹的风险。

JAMA. 2009 Feb 18;301(7):737-44. doi: 10.1001/jama.2009.146.

A Case of Pyoderma Gangrenosum in a Patient with Rheumatoid Arthritis Treated with Abatacept.1例使用阿巴西普治疗的类风湿关节炎患者发生坏疽性脓皮病的病例

Acta Derm Venereol. 2016 Aug 23;96(6):822-3. doi: 10.2340/00015555-2380.

Pulmonary infections in patients with rheumatoid arthritis who have received anti-TNF therapy.接受抗TNF治疗的类风湿关节炎患者的肺部感染

Intern Med. 2006;45(17):991-2. doi: 10.2169/internalmedicine.45.0156. Epub 2006 Oct 2.

Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.一名接受英夫利昔单抗治疗类风湿性关节炎的患者出现了新发银屑病。

Dermatol Online J. 2008 Sep 15;14(9):12.

Which TNF inhibitor for rheumatoid arthritis?哪种肿瘤坏死因子抑制剂用于治疗类风湿性关节炎？

Med Lett Drugs Ther. 2010 May 17;52(1338):38-9.

引用本文的文献

Repurposing Historic Drugs for Neutrophil-Mediated Inflammation in Skin Disorders.将历史悠久的药物用于治疗皮肤疾病中嗜中性粒细胞介导的炎症

Biomolecules. 2024 Nov 27;14(12):1515. doi: 10.3390/biom14121515.

Pyoderma gangrenosum following anti-TNF therapy in chronic recurrent multifocal osteomyelitis: drug reaction or cutaneous manifestation of the disease? A critical review on the topic with an emblematic case report.慢性复发性多灶性骨髓炎患者抗TNF治疗后发生坏疽性脓皮病：药物反应还是疾病的皮肤表现？结合典型病例报告对该主题的批判性综述

Front Med (Lausanne). 2023 May 31;10:1197273. doi: 10.3389/fmed.2023.1197273. eCollection 2023.

Tofacitinib shows benefit in conjunction with other therapies in recalcitrant hidradenitis suppurativa patients.托法替布与其他疗法联合使用时，对顽固性化脓性汗腺炎患者显示出疗效。

JAAD Case Rep. 2020 Jan 20;6(2):99-102. doi: 10.1016/j.jdcr.2019.10.010. eCollection 2020 Feb.

Paradoxical Skin Reactions to Biologics in Patients With Rheumatologic Disorders.风湿性疾病患者对生物制剂的反常皮肤反应。

Front Pharmacol. 2019 Mar 26;10:282. doi: 10.3389/fphar.2019.00282. eCollection 2019.

Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi-systematic review.坏疽性脓皮病和肿瘤坏死因子-α抑制剂：半系统综述。

Int Wound J. 2019 Apr;16(2):511-521. doi: 10.1111/iwj.13067. Epub 2019 Jan 3.

Biologic Agent-Associated Cutaneous Adverse Events: A Single Center Experience.生物制剂相关的皮肤不良事件：单中心经验

Clin Med Res. 2018 Jun;16(1-2):41-46. doi: 10.3121/cmr.2017.1364. Epub 2018 Apr 2.

Pyoderma gangrenosum and pyogenic arthritis presenting as severe sepsis in a rheumatoid arthritis patient treated with golimumab.接受戈利木单抗治疗的类风湿关节炎患者发生坏疽性脓皮病和化脓性关节炎并伴有严重脓毒症。

Rheumatol Int. 2018 Jan;38(1):161-167. doi: 10.1007/s00296-017-3861-8. Epub 2017 Oct 26.

Inflammatory Joint Disorders and Neutrophilic Dermatoses: a Comprehensive Review.炎性关节病与中性粒细胞皮肤病：全面综述。

Clin Rev Allergy Immunol. 2018 Apr;54(2):269-281. doi: 10.1007/s12016-017-8629-0.

Biological therapy for dermatological manifestations of inflammatory bowel disease.炎症性肠病皮肤表现的生物治疗

World J Clin Cases. 2013 May 16;1(2):74-8. doi: 10.12998/wjcc.v1.i2.74.

Off-label uses of anti-TNF therapy in three frequent disorders: Behçet's disease, sarcoidosis, and noninfectious uveitis.抗 TNF 治疗在三种常见疾病中的超适应证应用：白塞病、结节病和非感染性葡萄膜炎。

Mediators Inflamm. 2013;2013:286857. doi: 10.1155/2013/286857. Epub 2013 Aug 1.

本文引用的文献

Adalimumab therapy for recalcitrant pyoderma gangrenosum.阿达木单抗治疗顽固性坏疽性脓皮病。

J Burns Wounds. 2006 Nov 20;5:e8.

A medical conundrum: onset of psoriasis in patients receiving anti-tumour necrosis factor agents.一个医学难题：接受抗肿瘤坏死因子药物治疗的患者中银屑病的发病情况。

Ann Rheum Dis. 2006 Dec;65(12):1541-4. doi: 10.1136/ard.2006.059261.

Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial.英夫利昔单抗治疗坏疽性脓皮病：一项随机、双盲、安慰剂对照试验。

Gut. 2006 Apr;55(4):505-9. doi: 10.1136/gut.2005.074815. Epub 2005 Sep 27.

Pyoderma gangrenosum outside the context of inflammatory bowel disease treated successfully with infliximab.英夫利昔单抗成功治疗炎症性肠病以外的坏疽性脓皮病。

Clin Exp Dermatol. 2005 Mar;30(2):134-6. doi: 10.1111/j.1365-2230.2004.01681.x.

Treatment of multicentric reticulohistiocytosis with etanercept.用依那西普治疗多中心性网状组织细胞增生症。

Arch Dermatol. 2004 Aug;140(8):919-21. doi: 10.1001/archderm.140.8.919.

Infliximab as a treatment for recalcitrant pyoderma gangrenosum.

Clin Exp Dermatol. 2004 Mar;29(2):196-7. doi: 10.1111/j.1365-2230.2004.01470.x.

Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.英夫利昔单抗治疗与炎症性肠病相关的坏疽性脓皮病。

Am J Gastroenterol. 2003 Aug;98(8):1821-6. doi: 10.1111/j.1572-0241.2003.07581.x.

Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease.抗肿瘤坏死因子α单克隆抗体（英夫利昔单抗）用于治疗与克罗恩病相关的坏疽性脓皮病。

Eur J Dermatol. 2003 May-Jun;13(3):258-60.

Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-alpha therapy.对抗肿瘤坏死因子-α治疗有反应的进行性皮肤结节病

J Am Acad Dermatol. 2003 Feb;48(2):290-3. doi: 10.1067/mjd.2003.228.

Pyoderma gangrenosum associated with crohn disease: effect of TNF-alpha blockade with infliximab.与克罗恩病相关的坏疽性脓皮病：英夫利昔单抗阻断肿瘤坏死因子-α的效果

Scand J Gastroenterol. 2002 Sep;37(9):1108-10. doi: 10.1080/003655202320378338.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验